Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Pacira BioSciences Q3 Adj. EPS $0.70 Beats $0.65 Estimate, Sales $179.516M Miss $182.552M Estimate

Author: Benzinga Newsdesk | November 06, 2025 04:03pm
Pacira BioSciences (NASDAQ:PCRX) reported quarterly earnings of $0.70 per share which beat the analyst consensus estimate of $0.65 by 7.36 percent. This is a 11.39 percent decrease over earnings of $0.79 per share from the same period last year. The company reported quarterly sales of $179.516 million which missed the analyst consensus estimate of $182.552 million by 1.66 percent. This is a 6.49 percent increase over sales of $168.573 million the same period last year.

Posted In: PCRX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist